CD8+ as a Predictive Factor for Response to Anthracycline-Based Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer at Dr. Soetomo General Hospital, Surabaya, January 2024-August 2025. VER [Internet]. 2025 Nov. 25 [cited 2026 Jun. 28];8(13s):155-61. Available from: https://verjournal.com/index.php/ver/article/view/1000